Donate Email Signup Glossary Contact Us

Current News

BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients
Posted on April 26th 2008
Bristol-Myers Squibb Company announced new data from the E.A.R.L.Y. study, in which treatment of antiviral-naive adult chronic hepatitis B patients with Baraclude (entecavir) resulted in greater long-term viral load reduction than adefovir at 96 weeks - consistent with earlier 12-week results (primary endpoint). These data were presented last week in Milan, Italy, at the 43rd Annual Meeting of the European Association for the Study of the Liver.

Vertex reports promising hepatitis C drug results
Posted on April 24th 2008
Vertex Pharmaceuticals Inc. on Wednesday said early trial results show that its experimental hepatitis C treatment controlled or eradicated the virus in more than 80 percent of patients for whom previous treatment had failed. The trial results were presented in Milan at a meeting of the European Association for the Study of the Liver.

Sugarland, Nominated for 2008 CMT Awards, Names American Liver Foundation Charity of Choice
Posted on March 28th 2008
CMT will gift $2500 to charities of winners in each category. Your Vote for Sugarland is a Vote for the American Liver Foundation

Archived News

Nevada completes inspections in hepatitis C case
Posted on April 20th 2008
State health officials on Thursday completed inspections of all but two of 50 Nevada clinics checked following an outbreak of hepatitis C in six patients who went to a Las Vegas endoscopy center. Seven of the inspected clinics had "major infection control problems, such as the reuse of single-dose vials," according to a release from Gov. Jim Gibbons' office.

HCV Outbreaks at Dialysis Units Linked to Outmoded Infection Control
Posted on April 7th 2008
Four outbreaks of hepatitis C at dialysis centers between 1998 and 2006 were caused by infection control practices that disregarded CDC recommendations, according to an investigation by the agency.

Early-onset Obesity In Father Linked To Increased Potential For Liver Disease In Child
Posted on April 3rd 2008
A history of early-onset paternal obesity increases the odds of elevated liver enzyme levels in offspring and points to the potential for a genetic link between obesity and liver disease, according to a study in Gastroenterology.

New Method Disrupts Hepatitis C Virion Production
Posted on March 24th 2008
Timothy Tellinghuisen, an assistant professor in the Department of Infectology at Scripps Florida, and his colleagues used mutations of the viral NS5A phosphoprotein to disrupt virus particle production at an early stage of assembly.

FDA issues alert about HIV drug Prezista
Posted on March 24th 2008
The FDA said Prezista (darunavir), an anti-retroviral drug used to treat for the human immunodeficiency virus HIV, is suspected of contributing to several hepatic events, including liver failure, destruction of liver tissue, cirrhosis, hepatitis and jaundice.

Nevada completes inspections in hepatitis C case
Posted on March 20th 2008
State health officials on Thursday completed inspections of all but two of 50 Nevada clinics checked following an outbreak of hepatitis C in six patients who went to a Las Vegas endoscopy center. Seven of the inspected clinics had "major infection control problems, such as the reuse of single-dose vials," according to a release from Gov. Jim Gibbons' office.

Liver Health Today: ALF Welcomes New CEO
Posted on March 19th 2008
Liver Health Today features an article about American Liver Foundation CEO Rick Smith.

City Shuts Clinic Linked to Virus Cases
Posted on March 3rd 2008
The City of Las Vegas has shut down the Endoscopy Center of Southern Nevada, a clinic believed to have spread hepatitis C through shoddy practices. Officials are urging 40,000 people who received treatment at the center in the last four years to get tested for hepatitis C, a blood-borne virus, as well as H.I.V.

Biogen's Tysabri May Cause Liver Injury, U.S. Says
Posted on February 27th 2008
Biogen Idec Inc. and Elan Corp.'s multiple sclerosis medicine Tysabri may harm the liver within six days of the first dose, U.S. regulators said, urging doctors to warn patients about the risk.

Kava Linked To Liver Damage, New Evidence Shows
Posted on February 23rd 2008
Scientists have found new evidence that kava may have a negative effect on the liver. Kava is a plant native to the South Pacific that has been used as a ceremonial beverage in the region for thousands of years, and, more recently, as a natural treatment for medical conditions such as anxiety.

Report: Liver Cancer Deaths Rise 10% in Single Year
Posted on February 21st 2008
American Liver Foundation Recommends HCV Testing to Identify Cancer Risk

Fast food eaters risk liver damage, weight gain
Posted on February 14th 2008
Too much fast food and too little exercise can wreak havoc on the liver, according to results of a small Swedish study.

Discovery Of Good -- And Bad -- Liver Stem Cells Raises Possibility Of New Treatment
Posted on February 11th 2008
Researchers at Georgetown University Medical Center report that they have located stem cells in the liver that, when defective, may contribute to the development of liver cancer. The discovery suggests that a new type of experimental drug now being tested in other cancers might offer benefit in treating liver cancer.

Liver Transplants: Donor Organ Allocation System Analyzed
Posted on February 11th 2008
In the February issue of Mayo Clinic Proceedings, physicians explore how the current system for allocating donor organs in the United States affects outcomes for patients with end-stage liver disease.

Common Genetic Disease Found To Be Liver Disorder
Posted on February 8th 2008
In a joint effort, researchers from the European Molecular Biology Laboratory [EMBL] and the University of Heidelberg, Germany, have discovered that hereditary hemochromatosis is a disease that not just affects but indeed originates in the liver. They report that the disorder develops when a crucial gene is lacking in liver cells.

Grapefruit Compound May Help Combat Hepatitis C Infection
Posted on February 4th 2008
A compound that naturally occurs in grapefruit and other citrus fruits may be able to block the secretion of hepatitis C virus (HCV) from infected cells, a process required to maintain chronic infection.

American Liver Foundation Raises Awareness About Liver Disease at Rockefeller Center
Posted on January 7th 2008
Visit Rockefeller Plaza at 48th Street in New York City - steps away from the NBC Today Show - to view the American Liver Foundation's window display.

New Clues for Liver Cirrhosis Treatment
Posted on December 27th 2007
Working with mice, researchers have found a molecule that prevents - and even reverses - formation of scar tissue in damaged livers. The finding promises new treatments for cirrhosis and other scarring diseases of the liver.

After Hepatitis Case, New York State Acts to Speed Alerts to Patients at Risk
Posted on November 29th 2007
The state health commissioner, Dr. Richard F. Daines, has proposed a series of internal changes to prevent delays in notifying patients who might have been exposed to hepatitis C . This comes in the aftermath of news that a Long Island, NY doctor used improper procedures for preventing the spread of blood-borne diseases.

ALF Web Site Honored In National Web Competition
Posted on November 21st 2007
LiverFoundation.org Wins Silver Award in Health Care Category in 2007 W3 Awards.

AASLD: Liver Transplant for HBV-Related End-stage Liver Disease Drops Dramatically
Posted on November 4th 2007
The number of U.S. patients registered with the Organ Procurement and Transplantation Network for liver transplantation to treat liver disease secondary to hepatitis B virus (HBV) has decreased by 37% since 2000, according to a study. The decrease is likely the result of the widespread use of effective antivirals for HBV, according to W. Ray Kim, M.D.

FDA Approves Alternate Dosing Schedule For Twinrix
Posted on October 22nd 2007
Twinrix, the only hepatitis A and hepatitis B combination vaccine available in the U.S., has been approved by the FDA for an accelerated dosing schedule.

Hepatitis A Vaccine Best Bet to Treat Virus
Posted on October 18th 2007
CDC now recommends administering vaccine following exposure to hepatitis A virus instead of traditional immune globulin injection.

The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of the MS Society, As Chief Executive Officer
Posted on September 26th 2007
The American Liver Foundation announced today that Rick Smith has been named the next President and Chief Executive Officer of the Foundation, effective November 5, 2007.

Diet Change Can Curb Fatty Liver Disease
Posted on September 21st 2007
Diets high in quick-burning carbohydrates may cause fatty liver disease, which can lead to liver failure and death, according to a study in mice by researchers at Children's Hospital Boston. (The Washington Post)

Earlier Diagnosis And Treatment Of Primary Biliary Cirrhosis In Families Now Possible
Posted on September 14th 2007
Mayo Clinic researchers have found that first-degree relatives (i.e., parents, siblings, children) of patients with primary biliary cirrhosis (PBC) are more likely to have the biomarker of the disease in their blood.

The American Liver Foundation Mourns the Loss of a Heroic Hepatitis C Advocate
Posted on September 12th 2007
Anita Roddick, Founder of The Body Shop, Dies at Age 64.

Possible Hepatitis C Vaccine
Posted on September 6th 2007
In a collaborative effort with groups across Europe and the USA, scientists from The University of Nottingham have found monoclonal antibodies which may be a significant step towards a hepatitis C vaccine.

For Living Donors, Many Risks to Weigh
Posted on September 5th 2007
Jane Brody of The New York Times discusses the complex issues inherent in using living donors.

Cardiac Surgery In Patients With Liver Cirrhosis
Posted on July 9th 2007
A new study on the outcome of cardiac surgery in patients with liver cirrhosis found that the surgery can safely be performed in patients with milder disease, while those with more severe cirrhosis are less likely to survive according to the July 2007 journal Liver Transplantation.

Statins May Offer Liver Benefit
Posted on June 8th 2007
Statins may improve liver function in patients with chronic hepatitis C virus infection, according to a small pilot study

The Optimal Liver for Transplant in Hepatitis-C Patients
Posted on June 1st 2007
New research suggests that hepatitis C (HCV) infected patients receiving livers from HCV-infected donors have a slower rate of fibrosis progression at 1 year than those receiving uninfected livers.

New Test for Fatty Liver
Posted on June 1st 2007

Hepatitis C rises among young people
Posted on May 15th 2007
Hepatitis C infections among Massachusetts adolescents and young adults rose dramatically from 2001 to 2005, new data shows.

Hepatitis A and Hepatitis C Attack Same Protein to Block Immune Defenses
Posted on April 27th 2007
According to researchers these two otherwise unrelated liver viruses have one important thing in common: a trick for avoiding destruction by the immune system.

Gene Activates Liver Repair
Posted on April 19th 2007
Researchers may have identified a master switch that activates the liver's ability to heal itself.

FDA Licenses Product to Prevent Hepatitis B Reinfection
Posted on April 19th 2007
The Food and Drug Administration has announced the approval of HepaGam B for the prevention of hepatitis B reinfection in certain liver transplant patients.

Hepatitis C virus can block other hepatitis C variants from infecting the same cell
Posted on April 19th 2007
New research from Rockefeller University shows that the hepatitis C virus, can block other hepatitis C variants from infecting the same cell, preventing superinfection.

Outcomes for patients with hepatitis B who need liver transplants
Posted on March 7th 2007
A new study looks at the survival rates of hepatitis B patients requiring liver transplant.